Loading clinical trials...

COMPLETEDNANCT05413720

Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO

The research hypothesis is based on a suspected strong involvement of the immune system in the genesis of serious manifestations of the disease (hepatitis, renal failure, thrombocytopenia, intra-alveo...

Lead sponsor: Centre Hospitalier Universitaire de la Réunion•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Enrolling By Invitation

Xpert® Tropical Fever Test on GeneXpert® Edge X System

NCT07520279 · Malaria Fever, Zika, and more

Active Not RecruitingNA

Cohort of Hospitalized Patients Suspected of Leptospirosis

NCT04034550 · Leptospirosis

Not Yet RecruitingNA

Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI

NCT06945822 · Leptospirosis

COMPLETED

Seroprevalence of Leptospirosis in Val Müstair, Switzerland

NCT05300425 · Leptospirosis, Hepatitis E Virus Infection, and more

COMPLETED

Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine

NCT03497572 · Leptospirosis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 25, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment100

Start dateJan 2021

Last updatedOct 25, 2023

Condition

Leptospirosis

Locations shown

GHER

Saint-Benoît

CHU de la Réunion

Saint-Denis

CHOR

Saint-Paul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 25, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions